US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 5.850
  • -0.070-1.18%
Close Apr 19 16:00 ET
  • 5.850
  • 0.0000.00%
Post 16:03 ET
293.40MMarket Cap-2224P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
27.52%143.31M
7.31%34.86M
30.34%36.97M
36.69%37.22M
40.97%34.26M
54.20%112.38M
38.92%32.49M
42.75%28.36M
50.26%27.23M
111.25%24.3M
Selling and administrative expenses
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
47.70%7.02M
80.58%6.3M
186.28%6.39M
-General and administrative expense
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
47.70%7.02M
80.58%6.3M
186.28%6.39M
Research and development costs
30.81%111.27M
9.12%27.14M
32.63%28.31M
38.88%29.08M
49.34%26.76M
48.83%85.06M
37.16%24.87M
41.20%21.34M
43.03%20.94M
93.20%17.92M
Operating profit
-27.52%-143.31M
-7.31%-34.86M
-30.34%-36.97M
-36.69%-37.22M
-40.97%-34.26M
-54.20%-112.38M
-38.92%-32.49M
-42.75%-28.36M
-50.26%-27.23M
-111.25%-24.3M
Net non-operating interest income expense
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
7,569.23%997K
4,385.71%628K
2,383.33%149K
Non-operating interest income
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
7,569.23%997K
4,385.71%628K
2,383.33%149K
Other net income (expense)
-971.43%-1.04M
-175.27%-779K
-42.55%27K
-151.49%-69K
-197.74%-216K
110.61%119K
-328.79%-283K
161.11%47K
145.27%134K
128.41%221K
Gain on sale of security
-10,710.00%-1.06M
-175.27%-779K
-57.14%27K
-169.40%-93K
-325.00%-216K
106.17%10K
-328.79%-283K
250.00%63K
145.27%134K
-47.25%96K
Special income (charges)
-77.98%24K
--0
--0
--24K
--0
--109K
--0
---16K
--0
--125K
-Gain on sale of property,plant,equipment
-77.98%24K
--0
--0
--24K
--0
--109K
--0
---16K
--0
--125K
Income before tax
-24.44%-135.01M
-8.10%-33.27M
-27.07%-34.71M
-32.18%-34.99M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
-94.95%-23.93M
Income tax
338K
-22K
170K
190K
0
0
0
0
Net income
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
-94.95%-23.93M
Net income continuous Operations
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
-94.95%-23.93M
Minority interest income
Net income attributable to the parent company
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
-94.95%-23.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
-94.95%-23.93M
Basic earnings per share
-14.35%-2.63
9.52%-0.57
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
-34.88%-0.58
84.30%-0.57
-76.73%-0.51
Diluted earnings per share
-14.35%-2.63
9.52%-0.57
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
-34.88%-0.58
84.30%-0.57
-76.73%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 27.52%143.31M7.31%34.86M30.34%36.97M36.69%37.22M40.97%34.26M54.20%112.38M38.92%32.49M42.75%28.36M50.26%27.23M111.25%24.3M
Selling and administrative expenses 17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M47.70%7.02M80.58%6.3M186.28%6.39M
-General and administrative expense 17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M47.70%7.02M80.58%6.3M186.28%6.39M
Research and development costs 30.81%111.27M9.12%27.14M32.63%28.31M38.88%29.08M49.34%26.76M48.83%85.06M37.16%24.87M41.20%21.34M43.03%20.94M93.20%17.92M
Operating profit -27.52%-143.31M-7.31%-34.86M-30.34%-36.97M-36.69%-37.22M-40.97%-34.26M-54.20%-112.38M-38.92%-32.49M-42.75%-28.36M-50.26%-27.23M-111.25%-24.3M
Net non-operating interest income expense 147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M7,569.23%997K4,385.71%628K2,383.33%149K
Non-operating interest income 147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M7,569.23%997K4,385.71%628K2,383.33%149K
Other net income (expense) -971.43%-1.04M-175.27%-779K-42.55%27K-151.49%-69K-197.74%-216K110.61%119K-328.79%-283K161.11%47K145.27%134K128.41%221K
Gain on sale of security -10,710.00%-1.06M-175.27%-779K-57.14%27K-169.40%-93K-325.00%-216K106.17%10K-328.79%-283K250.00%63K145.27%134K-47.25%96K
Special income (charges) -77.98%24K--0--0--24K--0--109K--0---16K--0--125K
-Gain on sale of property,plant,equipment -77.98%24K--0--0--24K--0--109K--0---16K--0--125K
Income before tax -24.44%-135.01M-8.10%-33.27M-27.07%-34.71M-32.18%-34.99M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M-94.95%-23.93M
Income tax 338K-22K170K190K0000
Net income -24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M-94.95%-23.93M
Net income continuous Operations -24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M-94.95%-23.93M
Minority interest income
Net income attributable to the parent company -24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M-94.95%-23.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M-94.95%-23.93M
Basic earnings per share -14.35%-2.639.52%-0.57-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63-34.88%-0.5884.30%-0.57-76.73%-0.51
Diluted earnings per share -14.35%-2.639.52%-0.57-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63-34.88%-0.5884.30%-0.57-76.73%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg